A Community Partnership to Improve Access to Buprenorphine in a Homeless Population.  Leo P, Gastala N, Fleurimont J, Messmer S, Maes P, Richardson J, Neeb C, Stackhouse N, Koruba S, Watson DP.  Ann Fam Med. 2021 Jan-Feb;19(1):85. doi: 1…

Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID‐19 pandemic in New South Wales, Australia.  Roberts, J., White, B., Attalla, D., Ward, S., and Dunlop, A. J. (2021). Addictio…

The evolution of health care in the Texas correctional system and the impact of COVID-19.  Rao S, Ali K, Berdine G, Test V, Nugent K.  Proc (Bayl Univ Med Cent). 2020 Oct 12;34(1):76-80. doi: 10.1080/08998280.2020.1826258. PMID: 33456150…

USA:. HS Expands Access to Treatment for Opioid Use Disorder  The U.S. Department of Health and Human Services is publishing Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder*, to expand access t…

Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020.  Jones CM, Guy…

Experten-Web-Konferenz. Suchtbehandlung in Covid-Zeiten: der disruptive Zwang zur Innovation JATROS Neurologie & Psychiatrie 6/20, p. 27-29 19_J_Neuro_Kon_ÖGABS Experten-Web-Konferenz_Barth final